Skip Nav Destination
Issues
15 May 2009
-
Cover Image
Cover Image
Tibial tumor in mouse 5 weeks after injection of K-HOS osteosarcoma cells into the marrow space. The tumor has broken through the bone cortex and extends into the surrounding soft tissue. This histologic section shows tumor cells in contact with the periosteum and with newly formed woven bone adjacent to the bone cortex. For further details, please see Labrininidis and colleagues on page 3451 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
Molecular Pathways
Human Cancer Biology
Cancer Therapy: Preclinical
PCI-24781 Induces Caspase and Reactive Oxygen Species–Dependent Apoptosis Through NF-κB Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells
Savita Bhalla; Sriram Balasubramanian; Kevin David; Mint Sirisawad; Joseph Buggy; Lauren Mauro; Sheila Prachand; Richard Miller; Leo I. Gordon; Andrew M. Evens
Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients
Aude Bonehill; An M.T. Van Nuffel; Jurgen Corthals; Sandra Tuyaerts; Carlo Heirman; Violaine François; Didier Colau; Pierre van der Bruggen; Bart Neyns; Kris Thielemans
In vitro and In vivo Characterization of MDX-1401 for Therapy of Malignant Lymphoma
Pina M. Cardarelli; Maria-Cristina Moldovan-Loomis; Ben Preston; Amelia Black; David Passmore; Tseng-Hui Chen; Sharline Chen; Jie Liu; Michelle R. Kuhne; Mohan Srinivasan; Albert Assad; Alison Witte; Robert F. Graziano; David J. King
Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors
Wilmar Castillo-Ávila; Josep Maria Piulats; Xavier Garcia del Muro; August Vidal; Enric Condom; Oriol Casanovas; Josefina Mora; Josep Ramon Germà; Gabriel Capellà; Alberto Villanueva; Francesc Viñals
Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance
George N. Naumov; Monique B. Nilsson; Tina Cascone; Alexandra Briggs; Oddbjorn Straume; Lars A. Akslen; Eugene Lifshits; Lauren Averett Byers; Li Xu; Hua-kang Wu; Pasi Jänne; Susumu Kobayashi; Balazs Halmos; Daniel Tenen; Xi M. Tang; Jeffrey Engelman; Beow Yeap; Judah Folkman; Bruce E. Johnson; John V. Heymach
Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin's Lymphoma
David M. Vail; Douglas H. Thamm; Hans Reiser; Adrian S. Ray; Grushenka H.I. Wolfgang; William J. Watkins; Darius Babusis; Ilana N. Henne; Michael J. Hawkins; Ilene D. Kurzman; Robert Jeraj; Matt Vanderhoek; Susan Plaza; Christie Anderson; Mackenzie A. Wessel; Cecilia Robat; Jessica Lawrence; Daniel B. Tumas
Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin
Federico Rojo; Irene González-Navarrete; Rafael Bragado; Alba Dalmases; Silvia Menéndez; Maria Cortes-Sempere; Cristina Suárez; Cristina Oliva; Sonia Servitja; Vanesa Rodriguez-Fanjul; Isabel Sánchez-Pérez; Clara Campas; Josep Maria Corominas; Ignasi Tusquets; Beatriz Bellosillo; Sergi Serrano; Rosario Perona; Ana Rovira; Joan Albanell
Imaging, Diagnosis, Prognosis
Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival
Giuseppe Toffoli; Paola Biason; Antonio Russo; Elena De Mattia; Erika Cecchin; Claudia Maria Hattinger; Michela Pasello; Marco Alberghini; Cristina Ferrari; Katia Scotlandi; Piero Picci; Massimo Serra
Nuclear Factor-κB-Mediated Transforming Growth Factor-β-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy
Qiang Zhang; Brian T. Helfand; Thomas L. Jang; Lihua J. Zhu; Lin Chen; Ximing J. Yang; James Kozlowski; Norm Smith; Shilajit D. Kundu; Guangyu Yang; Adekunle A. Raji; Borko Javonovic; Michael Pins; Paul Lindholm; Yinglu Guo; William J. Catalona; Chung Lee
Cancer Therapy: Clinical
A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers
Joseph Baar; Paula Silverman; Janice Lyons; Pingfu Fu; Fadi Abdul-Karim; Nicholas Ziats; Jay Wasman; Paul Hartman; John Jesberger; Leda Dumadag; Erin Hohler; Rosemary Leeming; Robert Shenk; Helen Chen; Keith McCrae; Afshin Dowlati; Scot C. Remick; Beth Overmoyer
Phase I and Pharmacokinetic Study of Trabectedin as a 1- or 3-hour Infusion Weekly in Patients with Advanced Solid Malignancies
Bahram Forouzesh; Manuel Hidalgo; Quincy Chu; Alain Mita; Monica Mita; Garry Schwartz; José Jimeno; Javier Gómez; Vicente Alfaro; Claudia Lebedinsky; Patrik Zintl; Eric K. Rowinsky
An Imaging-Based Rapid Evaluation Method for Complement-Dependent Cytotoxicity Discriminated Clinical Response to Rituximab-Containing Chemotherapy
Yuji Mishima; Natsuhiko Sugimura; Yuko Matsumoto-Mishima; Yasuhito Terui; Kengo Takeuchi; Suzuka Asai; Daisuke Ennishi; Hiroaki Asai; Masahiro Yokoyama; Kiyotsugu Kojima; Kiyohiko Hatake
A Universal Formula Based on Cystatin C to Perform Individual Dosing of Carboplatin in Normal Weight, Underweight, and Obese Patients
Antonin Schmitt; Laurence Gladieff; Amélie Lansiaux; Christine Bobin-Dubigeon; Marie-Christine Etienne-Grimaldi; Michèle Boisdron-Celle; Françoise Serre-Debauvais; Frédéric Pinguet; Anne Floquet; Eliane Billaud; Chantal Le Guellec; Nicolas Penel; Mario Campone; Rémy Largillier; Olivier Capitain; Michel Fabbro; Nadine Houede; Jacques Medioni; Philippe Bougnoux; Isabelle Lochon; Etienne Chatelut
Letters to the Editor
Retraction
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.